277 related articles for article (PubMed ID: 19888515)
1. Heparin, heparan sulfate and heparanase in inflammatory reactions.
Li JP; Vlodavsky I
Thromb Haemost; 2009 Nov; 102(5):823-8. PubMed ID: 19888515
[TBL] [Abstract][Full Text] [Related]
2. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
Casu B; Naggi A; Torri G
Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
[TBL] [Abstract][Full Text] [Related]
3. Implications of heparan sulfate and heparanase in neuroinflammation.
Zhang X; Wang B; Li JP
Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
[TBL] [Abstract][Full Text] [Related]
5. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
[TBL] [Abstract][Full Text] [Related]
6. Heparanase involvement in physiology and disease.
Nasser NJ
Cell Mol Life Sci; 2008 Jun; 65(11):1706-15. PubMed ID: 18425416
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.
Ferro V
Expert Opin Ther Targets; 2013 Aug; 17(8):965-75. PubMed ID: 23789629
[TBL] [Abstract][Full Text] [Related]
8. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
Elli S; Guerrini M
Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
[TBL] [Abstract][Full Text] [Related]
9. Implications of Heparan Sulfate and Heparanase in Amyloid Diseases.
Li JP; Zhang X
Adv Exp Med Biol; 2020; 1221():631-645. PubMed ID: 32274729
[TBL] [Abstract][Full Text] [Related]
10. Molecular structure of heparan sulfate from Spalax. Implications of heparanase and hypoxia.
Sandwall E; Bodevin S; Nasser NJ; Nevo E; Avivi A; Vlodavsky I; Li JP
J Biol Chem; 2009 Feb; 284(6):3814-22. PubMed ID: 19068480
[TBL] [Abstract][Full Text] [Related]
11. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
Marchetti D; Liu S; Spohn WC; Carson DD
J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
[TBL] [Abstract][Full Text] [Related]
12. The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation.
Skidmore MA; Guimond SE; Rudd TR; Fernig DG; Turnbull JE; Yates EA
Connect Tissue Res; 2008; 49(3):140-4. PubMed ID: 18661329
[TBL] [Abstract][Full Text] [Related]
13. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
14. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Vlodavsky I; Ilan N; Naggi A; Casu B
Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
[TBL] [Abstract][Full Text] [Related]
15. Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo.
Ellyard JI; Simson L; Bezos A; Johnston K; Freeman C; Parish CR
J Biol Chem; 2007 May; 282(20):15238-47. PubMed ID: 17384413
[TBL] [Abstract][Full Text] [Related]
16. Human platelet heparanase: purification, characterization and catalytic activity.
Freeman C; Parish CR
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
[TBL] [Abstract][Full Text] [Related]
17. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
19. The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives.
Veraldi N; Zouggari N; de Agostini A
Molecules; 2020 Jan; 25(2):. PubMed ID: 31963505
[TBL] [Abstract][Full Text] [Related]
20. Heparin-protein interactions.
Capila I; Linhardt RJ
Angew Chem Int Ed Engl; 2002 Feb; 41(3):391-412. PubMed ID: 12491369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
